Literature DB >> 29846057

Molecular Probes for the Determination of Subcellular Compound Exposure Profiles in Gram-Negative Bacteria.

Benjamin Spangler1, Dustin Dovala1, William S Sawyer1, Katherine V Thompson1, David A Six1, Folkert Reck1, Brian Y Feng1.   

Abstract

The Gram-negative cell envelope presents a formidable barrier to xenobiotics, and achieving sufficient compound exposure inside the cell is a key challenge for the discovery of new antibiotics. To provide insight on the molecular determinants governing compound exposure in Gram-negative bacteria, we developed a methodology leveraging a cyclooctyne-based bioorthogonal probe to assess compartment-specific compound exposure. This probe can be selectively localized to the periplasmic or cytoplasmic compartments of Gram-negative bacteria. Once localized, the probe is used to test azide-containing compounds for exposure within each compartment by quantifying the formation of click-reaction products by mass spectrometry. We demonstrate this approach is an accurate and sensitive method of determining compartment-specific compound exposure profiles. We then apply this technology to study the compartment-specific exposure profiles of a small panel of azide-bearing compounds with known permeability characteristics in Gram-negative bacteria, demonstrating the utility of the system and the insight it is able to provide regarding compound exposure within intact bacteria.

Entities:  

Keywords:  Gram-negative permeability; bioorthogonal probes; click chemistry; compartment-specific exposure

Mesh:

Substances:

Year:  2018        PMID: 29846057     DOI: 10.1021/acsinfecdis.8b00093

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  1 in total

1.  Development of a bioorthogonal fluorescence-based assay for assessing drug uptake and delivery in bacteria.

Authors:  Jocelyn M F Ooi; Jessica M Fairhall; Benjamin Spangler; Daniel J W Chong; Brian Y Feng; Allan B Gamble; Sarah Hook
Journal:  RSC Adv       Date:  2022-05-23       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.